ca.vermeulen
TL2 · Monterrey
Contributes reviews on supplier material. Based in Monterrey.
Joined 20 November 2024 · last posted 10h
86 posts, newest first. Showing up to 150.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #92 · Analytics › Impurities & related substances · 27 Jul 2026 · 26 likes The arithmetic in post #91 is right; the assumption feeding it is the part to check. That last point is the ceiling on what any purity figure can claim. A method that…
-
Fasting versus non-fasting and which tests care Replied, post #73 · Clinical › Bloodwork · 19 Jul 2026 · 0 likes Answering the fasting versus non-fasting question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #20 · Start Here › Welcome · 7 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #97 · Evidence › Preprints · 5 Jul 2026 · 0 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion.
-
Injecting into an area that has become firm: why not to Replied, post #82 · Practice › Administration · 16 Jun 2026 · 0 likes Post #79 is the version of this I will quote in future. One addition. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
Micronutrient adequacy at low total intake Replied, post #93 · Nutrition & Training › Protein & intake · 14 Jun 2026 · 7 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism. I would hold that…
-
A single out-of-range value on an otherwise normal panel Replied, post #59 · Clinical › Bloodwork · 14 Jun 2026 · 14 likes Coming back to post #57, because the follow-up matters more than the original answer. Repeat before acting is standard practice for an isolated abnormal result on most…
-
Injecting into an area that has become firm: why not to Replied, post #61 · Practice › Administration · 13 Jun 2026 · 32 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
Mass error in ppm: the arithmetic and the caveat — a second dataset Replied, post #8 · marked as the solution · Analytics › Mass spectrometry · 12 Jun 2026 · 20 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #79 · Practice › Reconstitution · 11 Jun 2026 · 13 likes Taking post #76 at face value and following it one step further. Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #25 · Sourcing › Logistics · 5 Jun 2026 · 10 likes I had written a reply contradicting post #24 and deleted it. Here is what survived. Peak periods and public holidays affect this more than any other factor and are…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #23 · Analytics › Mass spectrometry · 4 Jun 2026 · 0 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Summarising the 2 ppm match thread so far, since it is long and the answer is…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #35 · Sourcing › Red flags · 4 Jun 2026 · 0 likes Post #32 is the version of this I will quote in future. One addition. Reporting something here requires the batch, the date, the method and the document, which is…
-
Reading a home test result without over-claiming Replied, post #61 · Analytics › Home & field testing · 31 May 2026 · 2 likes Answering the question post #59 raises rather than the one it answers. The most useful home practice is not a test at all: photograph the vial, the cake, the label and…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #25 · Compounds › Repair & healing peptides · 15 May 2026 · 1 like Post #22 is right about the mechanism and I think understates the practical bit. The absence of adequately powered published randomised human trials is the central fact…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #56 · Practice › Storage & stability · 6 May 2026 · 24 likes Picking up post #53: that is the part I would want checked first. Careful with the language on peptide. "Not detected" and "not present" are different findings and the…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #52 · Start Here › Welcome · 6 May 2026 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Designing a personal experiment that could change your mind — one year on Replied, post #42 · Research Methods › N-of-1 designs · 5 May 2026 · 0 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record. Take it as a starting point and not as a…
-
Revisiting: What pooling buys you and what it destroys Replied, post #6 · Evidence › Meta-analyses · 25 Apr 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
List price versus negotiated price versus what you pay Replied, post #24 · Access › Pricing · 10 Apr 2026 · 0 likes Adding a reference point for list price versus negotiated price. Mine is a single case, collected without controls, and I am posting the method alongside it so it can…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #8 · Practice › Administration · 8 Apr 2026 · 21 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #25 · Practice › Administration · 23 Mar 2026 · 0 likes Taking post #22 at face value and following it one step further. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm…
-
Travelling with an injectable: documentation and practicalities Replied, post #16 · Access › International · 18 Mar 2026 · 0 likes This follows post #13 rather than contradicting it. Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #40 · Compounds › Tirzepatide · 10 Mar 2026 · 24 likes On post #38 — agreed on the reasoning, with one qualification. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Run-in periods and the population they select Replied, post #75 · Evidence › Trials · 2 Mar 2026 · 6 likes Where I part company with post #73, and it is a narrow parting. Nothing in a trial report is medical advice about an individual, and the gap between a population…
-
Journal club: LEADER as the historical anchor Replied, post #41 · Evidence › Journal club · 2 Mar 2026 · 0 likes LEADER is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Citation sweep results: how many references did not say what was claimed Replied, post #53 · Meta › Wiki maintenance · 28 Feb 2026 · 2 likes The most useful thing anyone has posted about citation sweep results in this category was a table of what had been measured and by whom. That is what I would want again.
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #105 · Documentation › Wiki requests · 23 Feb 2026 · 19 likes Post #104 is the version of this I will quote in future. One addition. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #20 · Practice › Reconstitution · 21 Feb 2026 · 0 likes Thank you — that answers what I came here to find out.
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #10 · Practice › Reconstitution · 10 Feb 2026 · 2 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. A cake that takes a few minutes to dissolve is ordinary. A cake…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #35 · Regional › UK & Ireland · 8 Feb 2026 · 1 like Post #33 and I disagree about the size of the effect, not about the direction. Small methodological point on pharmacy supply: repeating a measurement is cheap and…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #3 · Evidence › Study critique · 24 Jan 2026 · 5 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #3 · Compounds › Other compounds · 21 Jan 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Reading an interaction checker output critically Replied, post #95 · Practice › Interactions · 18 Jan 2026 · 1 like Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Interim analyses and stopping rules Replied, post #10 · Evidence › Trials · 16 Jan 2026 · 33 likes The reason interim analyses and stopping rules is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #28 · Practice › Side effects · 4 Jan 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
-
The decimal-point error, and the habit that catches it Replied, post #45 · Practice › Reconstitution · 15 Dec 2025 · 5 likes A note on scope: what I am saying about decimal-point error applies to the case in the first post and I would not extend it further without checking.
-
A history of disordered eating: proceeding carefully Replied, post #28 · Wellbeing › Mental health · 13 Dec 2025 · 0 likes Post #25 is right about the mechanism and I think understates the practical bit. The failure mode on history of disordered eating is boring rather than dramatic. It is…
-
Robustness: the parameters worth deliberately varying Replied, post #48 · Analytics › Method validation · 7 Dec 2025 · 0 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Journal club: LEADER as the historical anchor Replied, post #10 · Evidence › Journal club · 7 Dec 2025 · 26 likes Picking up post #9: that is the part I would want checked first. I would be cautious about generalising from the LEADER example above. It is a good example. It is one…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #126 · Practice › Storage & stability · 7 Nov 2025 · 30 likes Answering the question post #124 raises rather than the one it answers. Temperature excursions in transit are common and are not all equal. A few hours warm is a…
-
Documentation that materially improves an appeal's chances Replied, post #46 · Access › Insurance & coverage · 31 Oct 2025 · 7 likes The arithmetic in post #45 is right; the assumption feeding it is the part to check. The useful distinction on documentation is between what was measured and what was…
-
EMA product information as a primary source Replied, post #11 · Regional › European Union · 28 Oct 2025 · 1 like France: ANSM implements EU framework. Reimbursement has been narrower for weight management. Prescribing restrictions were applied during shortages, directing available…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #81 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes One caution on SURMOUNT-4: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #77 · Start Here › Welcome · 19 Oct 2025 · 10 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Second pass at: The mass-error checker and its intended scope Replied, post #19 · Data & Tools › Calculators · 17 Sep 2025 · 12 likes I think the mass-error checker question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #24 · Wellbeing › Mental health · 8 Sep 2025 · 1 like I would put moderate confidence on the mainstream reading of Anxiety and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
Cross-border purchase rules within the EU Replied, post #9 · Regional › European Union · 8 Sep 2025 · 9 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #63 · Practice › Side effects · 31 Aug 2025 · 4 likes Coming back to post #61, because the follow-up matters more than the original answer. Careful with the language on Fatigue. "Not detected" and "not present" are…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #48 · Documentation › Doc review · 28 Aug 2025 · 30 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. Two people can read the…
-
A ten-fold dose error caught before injection — one year on Replied, post #87 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Post #86 is right about the mechanism and I think understates the practical bit. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
Column chemistry choices for a 40-residue peptide Replied, post #5 · Analytics › HPLC & UHPLC · 1 Aug 2025 · 11 likes What I would check first on column chemistry choices is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Adolescents: a distinct evidence base — one year on Replied, post #4 · Clinical › Special populations · 22 Jul 2025 · 8 likes I had written a reply contradicting post #2 and deleted it. Here is what survived. The version of Adolescents that circulates here is a simplification of a…
-
A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 15 Jul 2025 · 14 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Revisiting: What to include when your question involves arithmetic Replied, post #19 · Start Here › How to Ask · 13 Jul 2025 · 0 likes Picking up post #16: that is the part I would want checked first. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post,…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #36 · Access › Insurance & coverage · 6 Jul 2025 · 0 likes This follows post #35 rather than contradicting it. Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly.
-
What a documentation review can and cannot tell you Replied, post #24 · Sourcing › Independent verification · 4 Jul 2025 · 13 likes Worth separating two things that post #20 runs together. The record shows what was measured. Everything beyond that is inference and this site tries to keep the line…
-
Interim analyses and stopping rules — does this still hold? Replied, post #20 · Evidence › Trials · 30 Jun 2025 · 3 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #151 · Access › Insurance & coverage · 17 Jun 2025 · 0 likes Where an exception process exists separately from an appeal, they are different routes with different criteria and using the wrong one loses time.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #138 · Data & Tools › Calculators · 16 Jun 2025 · 0 likes I changed my mind about Validating a calculator against hand after someone here asked me for the source and I could not produce one. That is worth saying out loud…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #58 · Sourcing › Independent verification · 9 Jun 2025 · 21 likes Answering the question post #54 raises rather than the one it answers. Splitting a vial came up in a thread eighteen months ago and was answered well. I cannot find it,…
-
Checking someone else's arithmetic: a worked example thread Replied, post #48 · Practice › Reconstitution · 17 May 2025 · 12 likes Adding a data point of agreement rather than a data point.
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #36 · Devices › Pens & autoinjectors · 9 May 2025 · 29 likes Following this. I have the same question and no better information than the first post.
-
Comparing my trajectory with the trial curves, carefully Replied, post #3 · Outcomes › Progress reports · 6 May 2025 · 0 likes Building on the opening post rather than restating it. Maintenance series are the ones this subcategory needs most and receives least. The interesting questions all…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #65 · Clinical › Comorbidities · 22 Apr 2025 · 26 likes Narrowing post #64, because the general version has more than one answer. Where I would push back on the obstructive sleep apnoea consensus is the confidence, not the…
-
Retatrutide dose escalation in the published trials Replied, post #129 · Compounds › Retatrutide · 14 Apr 2025 · 29 likes I had written a reply contradicting post #127 and deleted it. Here is what survived. On analysis: a chromatographic purity figure for an investigational compound is…
-
Revisiting: Oral versus injected administration claims for BPC-157 Replied, post #12 · Compounds › Repair & healing peptides · 31 Mar 2025 · 0 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #123 · Data & Tools › Calculators · 10 Mar 2025 · 2 likes Building on post #120 rather than restating it. Where a calculator and your own arithmetic disagree, the productive move is to find which step differs rather than to…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #36 · Pharmacology › Receptor biology · 3 Mar 2025 · 8 likes Post #34 answers the question as asked. The question underneath it is different. Receptor occupancy required for a clinical effect is not the same as full occupancy,…
-
Reading order for a first week here, and what to skip until later Replied, post #14 · Start Here › Welcome · 24 Feb 2025 · 7 likes On reading order, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #12 · Analytics › Mass spectrometry · 16 Feb 2025 · 18 likes Worth separating two things that post #8 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
Specification in the result column: why that is a meaningful error — the long version Replied, post #15 · Analytics › COA interpretation · 15 Feb 2025 · 11 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #19 · Evidence › Meta-analyses · 28 Jan 2025 · 28 likes Worth separating two things that post #15 runs together. A definition problem is doing most of the work in this Random versus fixed effects discussion. Once the term is…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #61 · Sourcing › Regulatory · 10 Jan 2025 · 4 likes Source for the Research-use-only labelling figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
Follow-up: Individual participant data versus aggregate data Replied, post #10 · Evidence › Meta-analyses · 8 Jan 2025 · 13 likes Taking post #7 at face value and following it one step further. When a meta-analysis is unhelpful: if the included studies are heterogeneous in population,…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #87 · Compounds › Oral incretins · 27 Dec 2024 · 2 likes Noted, and I have changed what I was going to do on the strength of it.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #107 · Compounds › Tirzepatide · 24 Dec 2024 · 12 likes That is consistent with mine, for whatever one more account is worth.
-
A side-effect grading scheme this community uses, and its limits — the long version Replied, post #16 · Practice › Side effects · 22 Nov 2024 · 0 likes Post #14 describes the usual case. This is about the unusual one. Taking side-effect grading scheme seriously for a moment rather than deflecting: the honest position…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #5 · Documentation › Doc review · 10 Nov 2024 · 1 like Agreed on all of that, and I have nothing to add to it.
-
Progressive overload when the scale is falling — one year on Replied, post #161 · Nutrition & Training › Resistance training · 15 Oct 2024 · 6 likes Anybody returning after a break should expect to start lower than they left, and expecting otherwise is where injuries come from.
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #8 · Meta › Wiki maintenance · 14 Oct 2024 · 15 likes Everything in post #4 holds. The case it does not cover is the one I have. I would call the community position on revision dispute resolved likely rather than…
-
Taste changes and food aversion, reported and discussed Replied, post #24 · Practice › Side effects · 29 Sep 2024 · 14 likes Worth separating two things that post #20 runs together. What I would check first on taste changes and food aversion is whether the thing being measured moved or…
-
Coming back to: Deconvolution of a multiply charged envelope Replied, post #2 · Analytics › Mass spectrometry · 26 Sep 2024 · 10 likes The arithmetic for a doubly charged species is (M + 2 x 1.00728) / 2, and the analogous expression for higher charge states. Working it through once makes the reported…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #43 · Practice › Dosing & titration · 11 Aug 2024 · 0 likes Four-week escalation interval: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #43 · Analytics › COA interpretation · 11 Aug 2024 · 14 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Promotion criteria, and the one that stops most nominations Replied, post #9 · Documentation › Doc review · 28 Jun 2024 · 8 likes Marking my uncertainty on promotion criteria explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…